摘要
目的:探讨胰岛素敏感性的改善对非糖尿病、非肥胖患者,择期经皮冠状动脉介入治疗术(PCI)后心血管事件的影响。方法:连续入选2013年1月至2014年1月间,因心绞痛住院并接受择期PCI治疗的非糖尿病、非肥胖胰岛素抵抗(HOMA-IR≥2.92)患者147例。所有患者术后接受规范的药物治疗和生活方式指导。根据术后6个月HOMA-IR结果将患者分为IR改善组(n=45)和IR持续组(n=102)。随访1年,观察两组患者主要心血管事件(死亡、非致死性心肌梗死、再次血运重建及支架血栓)的发生率。结果:与IR持续的患者相比,IR改善的患者靶血管(12.7%vs.2.2%,P=0.05)和靶病变(11.8%vs.2.2%,P=0.06)血运重建的发生率低;心血管事件的发生率(22.5%vs.13.3%,P=0.20)差异无统计学意义。多因素Cox比例危险度模型分析显示,持续吸烟是PCI术后心血管事件的独立预测因素(HR=7.68,95%CI:3.63-16.22,P〈0.00)。结论:短期胰岛素敏感性的改善对PCI术后心血管事件无显著影响,持续吸烟是预测PCI术后心血管事件的独立危险因素。
Objective:Insulin resistance (IR) is a predictor of cardiovascular (CV) events even before the onset of diabetes. However, it is unclear whether improved the insulin sensitivity may affect long-term outcome in patients undergoing pereutaneous coronary intervention (PCI). Methods: The study enrolled 147 non- diabetic patients with newly diagnosed CAD and IR. All patients received optimized therapy including medica- tions and lifestyle changes. Evaluation of IR was repeated at 6 months after PCI. All patients were prospectively followed-up for one year or until the occurrence of one of the following events: death, nonfatal myocardial infarction, coronary revascularization and in-stent thrombosis. Results : IR was improved in 45 ( 30. 6% ) patients. During the follow-up, target vessel revascularization ( 12. 7% vs. 2. 2% , P =0. 05) and target lesion revascularization ( 11.8% vs. 2. 2%, P =0. 06) were lower in patient with improved IR status, but the incidence of major cardiovascular events was no significant difference between two groups ( 22. 5% vs. 13.3% , P = 0. 20). Multivariate Cox proportional hazards analysis identified that persistent smoking but not persistent IR was an independent predictor of future CV events (HR = 7. 68, 95% CI 3.63-16. 22, P 〈 0. 00). Conclusion: Improved IR sensitivity was not associated with the decreased CV events after PCI. The persistent smoking was an independent risk factor for CV events after PCI.
出处
《心肺血管病杂志》
2016年第9期700-704,共5页
Journal of Cardiovascular and Pulmonary Diseases
基金
北京市医院管理局临床医学发展专项经费(编号:ZYLX201303)
北京市医院管理局"登峰"计划(DFL20150601)
国家临床重点专科建设项目(2013-2014年度)
关键词
非糖尿病
胰岛素抵抗
经皮冠状动脉介入治疗
心血管事件
Non-diabetic
Insulin resistance
Pereutaneous coronary intervention
Cardiovascular events